title: Patterns of psychotropic medication prescriptions by psychiatrists for private clinic outpatients in kerman province, iran.
abstract: OBJECTIVE
  The aim of this study was to assess the pattern and utilisation of psychotropic drug prescriptions by psychiatrists in Kerman Province, Iran.
  
  
  METHODS
  The prescriptions of 27 psychiatrists were randomly selected from two Iranian public insurance organisations and were analysed for the mean number of drugs/prescriptions, drug category and the most frequently prescribed drug in each category as well as overall.
  
  
  RESULTS
  A total of 6,414 prescriptions were analysed. The mean number of drugs per prescription was 2.9. Antidepressants (61.0%) were the most frequently prescribed category of psychotropic medications, followed by antipsychotics (29.5%), sedative/hypnotics or anti-anxiety drugs (27.5%) and mood stabilisers (18.5%). The combination of antidepressants with antipsychotics was the most commonly prescribed combination (18.8%). Fluoxetine (16.5%) and trifluoperazine (13.5%) were among the most frequently prescribed antidepressants and antipsychotics, respectively. Clonazepam (10.5%) was the most commonly prescribed benzodiazepine agent, followed by alprazolam (8.5%). In terms of total drug utilisation, sertraline (12.4%) was the most commonly used psychotropic medication followed by fluoxetine (9.7%), trifluoperazine (6.6%), propranolol (4.5%) and clonazepam (3.7%).
  
  
  CONCLUSIONS
  A high proportion of psychotropic prescriptions in Kerman Province were for antidepressants, followed by antipsychotics and the benzodiazepines. Further research is needed to determine the underlying correlation between prescription practice and the diagnosis and patient characteristics, as well as to investigate the use of different psychotropic medications.
authors.affiliation: Neuroscience Research Center, Kerman University of Medical Sciences, Kerman, Iran;
authors.forename: Abdolreza
authors.initials: A
authors.lastname: Sabahi
authors.affiliation: Neuroscience Research Center, Kerman University of Medical Sciences, Kerman, Iran;
authors.forename: Gholamreza
authors.initials: G
authors.lastname: Sepehri
authors.affiliation: Kerman Social Security Organization, Kerman, Iran;
authors.forename: Mottahareh
authors.initials: M
authors.lastname: Mohsenbeigi
authors.affiliation: Tehran University of Medical Sciences, Tehran, Iran.
authors.forename: Ehsan
authors.initials: E
authors.lastname: Sepehri
keywords: Iran; Prescriptions, trends; Prescriptions, utilization; Psychiatrists; Psychotropic Drugs
references.citation: Arch Gen Psychiatry. 2010 Jan;67(1):26-36
references.pmid: 20048220
references.citation: Int J Health Care Qual Assur Inc Leadersh Health Serv. 2005;18(4-5):353-60
references.pmid: 16167650
references.citation: J Affect Disord. 2000 Apr;58(1):19-36
references.pmid: 10760555
references.citation: Psychiatr Serv. 2001 Aug;52(8):1081-7
references.pmid: 11474055
references.citation: Epidemiol Psychiatr Sci. 2012 Mar;21(1):87-95
references.pmid: 22670416
references.citation: Int Clin Psychopharmacol. 2012 Sep;27(5):256-66
references.pmid: 22842799
references.citation: Ann Clin Psychiatry. 2005 Jul-Sep;17(3):147-52
references.pmid: 16433056
references.citation: Arch Gen Psychiatry. 2012 Dec;69(12):1247-56
references.pmid: 22868273
references.citation: Indian J Psychol Med. 2011 Jan;33(1):54-8
references.pmid: 22021954
references.citation: J Pak Med Assoc. 2005 Jun;55(6):259-63
references.pmid: 16045100
references.citation: J Am Acad Child Adolesc Psychiatry. 2005 Jun;44(6):548-56
references.pmid: 15908837
references.citation: Arch Pediatr Adolesc Med. 2003 Jan;157(1):17-25
references.pmid: 12517190
references.citation: Psychiatr Serv. 2006 Jan;57(1):63-9
references.pmid: 16399964
references.citation: Aust N Z J Psychiatry. 2003 Feb;37(1):55-61
references.pmid: 12534657
references.citation: J Clin Epidemiol. 1998 Mar;51(3):273-83
references.pmid: 9495693
references.citation: Int J Neuropsychopharmacol. 2011 Oct;14(9):1157-64
references.pmid: 21557883
references.citation: Eur Child Adolesc Psychiatry. 2012 Sep;21(9):477-92
references.pmid: 22763750
references.citation: Arch Gen Psychiatry. 2009 Aug;66(8):848-56
references.pmid: 19652124
references.citation: BMJ. 2003 May 10;326(7397):1014
references.pmid: 12742924
references.citation: J Pak Med Assoc. 2011 Jun;61(6):566-71
references.pmid: 22204212
references.citation: J Epidemiol Community Health. 2012 Nov;66(11):990-4
references.pmid: 22516739
references.citation: Aust N Z J Psychiatry. 2012 Dec;46(12):1159-64
references.pmid: 22790175
references.citation: Psychiatry Clin Neurosci. 2007 Oct;61(5):522-8
references.pmid: 17875031
references.citation: Ambul Pediatr. 2006 Mar-Apr;6(2):79-83
references.pmid: 16530143
references.citation: Eur Neuropsychopharmacol. 2013 Jun;23(6):555-60
references.pmid: 22709890
references.citation: Int J Health Care Qual Assur. 2012;25(7):582-91
references.pmid: 23276054
references.citation: Curr Opin Psychiatry. 2008 Nov;21(6):645-50
references.pmid: 18852575
references.citation: Drugs. 1994 Jul;48(1):25-40
references.pmid: 7525193
references.citation: Pharmacoepidemiol Drug Saf. 2002 Sep;11(6):515-22
references.pmid: 12426937
references.citation: Australas Psychiatry. 2012 Aug;20(4):301-4
references.pmid: 22773413
references.citation: Arch Gen Psychiatry. 1998 Apr;55(4):310-6
references.pmid: 9554426